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ABSTRACT 
This study aimed to predict the potential activity and interaction conformation of polyphenolic compounds from 
Peperomia pellucida (L) Kunth (nine compounds) with angiotensin-converting enzyme (ACE) macromolecule by in 
silico molecular docking study. The crystal structure of ACE as a molecular target was obtained from the PDB database 
(PDB ID: 1UZF) with captopril as a native ligand. Molecular docking analysis was performed using AutoDockZn (100 
docking runs) based on the active site of Zn2+, the central grid was placed on Zn2+ with a box size of 40Á × 40Á × 
40Á and a center of 40.835Á × 34.382Á × 44.607Á for selective inhibitors (MCO702) with a spacing of 0.375Á. 
Based on the docking results demonstrated that the prediction of each polyphenol compounds from P. pellucida has 
the potential of active as ACE inhibitors, it was indicated that docking results of each compound has lower affinity 
compared to captopril (with binding affinity of −6.36 kcal/mol and the inhibition constant 21.81 μM), where the 
most moderate binding affinity (the most potential) was tetrahydrofuran lignin ((1R,2S,3S,5R)-3,5-bis(4-hydroxy-
3,5-dimethoxyphenyl)cyclopentane-1,2-diyl)bis-(methylene) diacetate) of −8.66 kcal/mol and the highest binding 
affinity (the less potential) was dillapiole (6-allyl-4,5-dimethoxybenzo[d][1,3]dioxole) of −4.99 kcal/mol, although 
with different forms of interaction, bond, and constant inhibition. Based on the interaction of ACE binding site, 
5,6,7-trimethoxy-4-(2,4,5-trimethoxyphenyl)-3,4-dihydronaphthalen-1(2H)-one showed the most similar interaction 
with the captopril ligand. These results are preliminary data for further research with predictions of target compound 
biological activity and interaction quickly, accurately, and inexpensively.
INTRODUCTION
Hypertension or high blood pressure is one of the most 
top prevalent diseases in the world (Sorlie et al., 2014). In 2010, 
it was estimated 31.1% of adults worldwide had hypertension 
(Mills et al., 2016) and is predicted to increase by about 60% by 
2025 (Kearny et al., 2005). Also, hypertension may increase risk 
factors for cardiovascular disease and has been associated with 
complications, such as stroke, heart attack, and kidney failure 
(Hartmann and Meisel, 2007). 
One of the primary therapeutic agents for the treatment of 
hypertension is angiotensin-converting enzyme (ACE) inhibitors. 
ACE is one component of the renin-angiotensin-aldosterone 
system and plays a crucial role in the regulation of blood pressure 
(Skeggs et al., 1953; 1957). Metalloprotein residue of Zn2+ in ACE 
cleaves the His-Leu dipeptide from the inactivated C angiotensin I 
terminal (Ang I) and converting it into a potent vasoconstrictor in 
the form of angiotensin II (Unger, 2002). ACE has two isoforms, 
*Corresponding Authors
Islamudin Ahmad, Department of Pharmaceutical Sciences, Faculty 
of Pharmacy, Mulawarman University, Samarinda, East Kalimantan, 
Indonesia. E-mail: islamudinahmad @ farmasi.unmul.ac.id  
and  
Abdul Mun'im, Department of Pharmaceutical Sciences, Faculty of 
Pharmacy, Universitas Indonesia, Depok, West Java, Indonesia. 
E-mail: munimabdoel @ gmail.com
© 2019 Islamudin Ahmad et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License  
(https://creativecommons.org/licenses/by/4.0/).
DOI: 10.7324/JAPS.2019.90804.1
Ahmad et al. / Journal of Applied Pharmaceutical Science 9 (08); 2019: 025-031 026
including: (1) glycoprotein form in somatic tissue with single 
large polypeptide chain of 1,277 amino acid and (2) in germinal 
cells that are synthesized in the form of lower molecular mass 
and play a role in sperm maturation and sperm binding of oviduct 
epithelium (Natesh et al., 2003; 2004). Currently, the crystal 
structure data from ACE is available in the form of PDB files that 
can be used for in silico molecular docking study.
In recent years, modeling methods based on computer 
simulations have become a useful tool in solving many scientific 
and engineering problems (Forli et al., 2016). In some conditions, 
computer-based modeling methods have become a bridge 
between applied or experimental science and theories of natural 
sciences, such as physics, chemistry, and biology quickly and 
precisely. When the simulation is compared with the experiment, 
it sometimes gives slightly different results (Ramachandran et al., 
2008). Molecular docking is a process that searches for possible 
bonds of two molecules interacting under topographical conditions 
or energy considerations, the goal being to match the two 
molecules to the conformation in which has the best interaction 
(Santos-Martins et al., 2014; Seeliger and de Groot, 2010). One 
molecule (ligand) is docked to another molecular region (receptor) 
and from both molecules are calculated its interaction energy. In 
docking, its interaction energy is calculated by Van der Waals 
energy and Coulombic energy involved between all the atoms of 
both molecules (Ghosh and Gemma, 2014). 
Natural products (mainly from plants) are the primary 
source for new drugs discovery. One of the herbs empirically 
used as a hypertension drug by the community in some countries 
is Peperomia pellucida (L) Kunth herb. According to the study 
reported by Saputri et al. (2015), the methanol extract of P. 
pellucida has ACE inhibitory activity with IC50 of 7.17 μg/ml and 
(Kurniawan et al., 2016) has reported that fraction and isolated 
quercetin of P. pellucida herb has IC50 of 3.44 and 7.22 μg/ml, 
respectively. Some polyphenols isolated from this herb includes 
secolignan (peperomins) and lignin (Xu et al., 2006), pellucidin A 
(Bayma et al., 2000), patuloside A (Khan et al., 2010), dillapiole 
(Rojas-Martínez et al., 2013), chromenes (Susilawati et al., 2015), 
and quercetin (Kurniawan et al., 2016). However, a study on 
ACE inhibitory activity (except quercetin) and the prediction of 
interaction conformation with ACE has not been reported.
In the present study, prediction of activity potency 
and interaction conformation of isolates from P. pellucida herbs 
with ACE have been conducted, which thus may expedite the 




For in silico molecular docking study, a computer ASUS® 
(Taipei, Taiwan) with following specifications was used: processor 
Intel® Core™ i5-5200U CPU @2.20 GHz 2.19 GHz, 4.00 GB 
memory (RAM) DDR3, 64-bit Operating System, ×64-based 
processor, Windows Education 10.1, and NVIDIA GEFORCE 
820 M VGA. Software installed includes ChemOffice Pro v15.00 
PerkinElmer, Chimera 1.10.2., Ligplot+ v.1.4.5, AutoDockZn (http://
autodock.scripps.edu/resources/autodockzn-forcefield), AutoDock 
v4.2.6 and AutoDockTools (http://autodock.scripps.edu/), Amber14 
(operated via putty to connect with the server), Pymol, OpenBabel 
GUI, and PMV 1.9.2 (Phyton Molecular Viewer). 
Receptor and native ligand structure preparation
The crystal structure of ACE (angiotensin-converting 
enzyme) in complex with captopril was downloaded from Protein 
Data Bank (rcsb.org/pdb/) with PDB id: 1UZF with 2.0 Å resolution. 
Ligand-protein docking was performed using AutodockZn 
program. AutoDockTools and OpenBabel programs were used to 
prepare and convert the type of the macromolecule complex and 
ligand file (O’Boyle et al., 2011). Furthermore, water molecules 
were removed from the macromolecule protein 1UZF; then the 
complete structure was converted, and hydrogen atom addition 
was done using Leap module of AMBER 14. The ligand file was 
subjected to the calculation of AM1-BCC partial atomic charges 
using antechamber module of AMBER 14 and minimization was 
done using Amber force field ff99SB. Then, the output (.crd) was 
converted to PDB by an ambpdb module of AMBER 14. 
Ligand sample preparation
Structure of Ligand samples was acquired from some 
literature (as can be seen in Table 1) (Bayma et al., 2000; Khan 
et al., 2010; Kurniawan et al., 2016; Rojas-Martínez et al., 2013; 
Susilawati et al., 2015; Xu et al., 2006). 2D structure of ligand 
samples was built using ChemDraw® Pro 15 and was converted to 
the 3D structure using Chem3D® Pro 15. The MMFF94 atom types 
and charges of ligand samples were calculated, then minimization 
was performed using the MMFF94 force field minimization of 
Chem3D® Pro 15 (Wang et al., 2015). The minimized structure 
was converted to PDB format.
In silico molecular docking analysis
Docking of all the ligand samples was conducted using 
AutoDockZn (O’Boyle et al., 2011). The program was begun with 
ligands in different conformations and found the best docking 
on binding-site proteins using a Lamarckian Genetic Algorithm 
(LGA) to make one possible formation. The docking simulation 
was performed for the isolated compound using a protein receptor 
(PDB id: 1UZF). The autogridZn program was used to calculate 
the position of the grid. Based on the active site of Zn2+, the central 
grid was placed on Zn2+ with a box size of 40Á × 40Á × 40Á 
and a center of 40.835, 34.382, and 44.607 for selective inhibitors 
(MCO702) with a spacing of 0.375. The docking procedure was 
done using autodockZn program with 100 docking runs. Docking 
results were visualized using LigPlot+ and Poseview (Laskowski 
and Swindells, 2011; Stierand and Rarey, 2010).
RESULTS AND DISCUSSION
In silico molecular docking study aims to determine the 
potential of active compounds from natural products or synthetic. 
It is an approach for predicting potentially active compound based 
on the interaction and bonds types between the ligand and the 
active site of the receptor. This method is beneficial to predict the 
biological activity and interaction of ligand compounds quickly, 
accurately, and inexpensively. 
In present study, in silico molecular docking study 
was performed to predict the potency of activity and interaction 
between ligand molecules in the form of native ligand (captopril) 
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Table 1. The IUPAC name and chemical structure of polyphenols compound from P. pellucida.














cyclopentyl)methyl acetate (tetrahydrofuran lignin)















(Khan et al., 2010)










(Kurniawan et al., 2016)
Ahmad et al. / Journal of Applied Pharmaceutical Science 9 (08); 2019: 025-031 028
and the isolated polyphenol compounds of P. pellucida (consisting 
of nine compounds as listed in Table 1) on the ACE macromolecule 
(PDB id: 1UZF). 
The docking of native ligand (captopril) gave Root Mean 
Square Deviation (RMSD) value of 0.96Á (<2), which means 
the docking results were valid with a ∆G value of −6.36 and 
clusters of 92% for the total of 100 times running. As can be seen 
in Figure 1, it shows the position between the native ligand and 
the docking results does not show significantly different locations 
(with the RSMD value <2). Figure 2 demonstrates the interaction 
between groups of the native ligand with protein (amino acid) 
and Zn2+ metalloprotein groups of an ACE macromolecule using 
LigPlus (A), PoseView (B). The binding mode of captopril in ACE 
macromolecule complex was investigated from its crystal structure 
(ID 1UZF). It is shown that the COOH and C=O groups of captopril 
formed hydrogen bonds with Tyr520, Lys511, Gln281 (with 
COOH) and His353, His513 (with C=O), respectively. The S-H 
group formed interaction with metalloproteins Zn2+ (with an atomic 
distance of 2.3 Å) and formed hydrogens bonding with Glu384. 
The bond forms of ligands from the docking results involved the 
hydrogen and hydrophobic bonds on clusters of amino acids and 
its interactions in the Zn2+ metalloprotein according to studies has 
been reported by Chang and Alli (2012) and Sharifi et al. (2013). 
This interaction (with distances of < 3 Å) indicated that the active 
site of each ligand has interaction with ACE macromolecule. In 
Figure 3, the binding mode of each compound in macromolecule 
demonstrated that the groups of each compound (except Compound 
8) formed interaction with Zn2+ and Glu384. Meanwhile, His353, 
His513, and Tyr523 had interactions (hydrogen and hydrophobic 
bond) with groups of each compound, and another hand, another 
amino acid group had different interactions. 
Meanwhile, Table 2 demonstrates that the prediction 
of polyphenols compound from P. pellucida has potential to 
be developed as ACE inhibitors, it was indicated that docking 
results of each compound have lower affinity than captopril 
(with a binding affinity of −6.36 kcal/mol and the inhibition 
constant 21.81 μM) except Compound 7. Based on the results 
of calculation and docking analysis, similarity was exhibited 
between polyphenol compounds (except compound 7) with the 
native ligand. In the previous study, Guerrero et al. (2012) have 
predicted the interaction and bonds of luteolin (polyphenols 
Figure 1. Visualization of comparison between original and docking results 
position of the native ligand. Where a red is original crystallography and purple 
is docking results.
Figure 2. Visualization of docking results interaction between the native ligand and residue of ACE macromolecule (PDB: 1UZF) 
using (A) Ligplotplus and (B) dan Poseview.
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group) using QSAR and molecular docking study of quercetin as 
a potential ACE inhibitor has been reported by Muhammad and 
Fatima (2015). Each amino acid residue can form seven different 
bonds or interactions with the ligand includes: (1) interaction of 
van der Waals bond, (2) interaction of aromatic face to face, (3) 
interaction of aromatic edge to face, (4) interaction of H-bond or 
protein as donor, (5) interaction of H-bond or protein as acceptor, 
(6) interaction of protein positively charged, and (7) interaction 
of protein negatively charged (Radifar et al., 2013). In addition, 
Table 2 also shows that some compounds have a potential active 
site with interaction distance between O atoms (ligand groups) and 
Zn2+ metalloprotein (protein receptor residue) at values less than 
3Å, includes Compound 3, Compound 4, Compound 5, Compound 
6, Compound 8, and Compound 9 with constant inhibition 752.52, 
448.43, 10,740, 2,470, 517.42, and 831.04 nM, respectively. On 
other hands, Zn2+, Glu384, His513, His353, Gln281, Tyr520, 
Tyr523, and Lys511 are the binding site of ACE. The native ligand 
of captopril performs hydrogen bonding (Zn2+, Glu384, His513, 
His353, Gln281, Tyr520, and Lys511) and hydrophobic interaction 
(Tyr523). Based on the results of docking analysis, compound 5 
has the most similar interaction with the captopril ligand where the 
compound binds to the active side of ACE as can be seen in Table 2, 
and these prediction results are in accordance with the molecular 
docking results of polyphenol compounds from Phyllanthus niruri 
herbs (Ahmad et al., 2018). In addition, some study has reported 
that extracts and fractions (with rich in polyphenol content) of 
this herbs have activity as an ACE inhibitor using in vitro assay 
method (Adhitia et al., 2017; Mun'im et al., 2017; Rinayanti et al., 
2013; Saputri et al., 2015). Meanwhile, according to the previous 
study, Kurniawan et al. (2016) have done the assay of ACE 
inhibitory activity of Compound 9 (quercetin) with IC50 of 16.21 
nM which has excellent correlation with the obtained docking 
Figure 3. Visualization of docking results interaction of isolated polyphenols from P. Pellucida and ACE macromolecule receptor (PDB: 1UZF) by 
Ligplotplus software.
Table 2. The docking results of captopril and polyphenol compounds from P. pellucida.





Interaction of ACE binding site
Zn2+ Glu384 His513 His353 Gln281 Tyr520 Tyr523 Lys511
1 Captopril (Native) - - - √ √ √ √ √ √ √ √
2 Captopril redocked −6.36 21,810 2.3 √ √ - √ √ √ √ √
3 Compound 1 −8.08 1,190 3.3 √ √ - √ - - √ -
4 Compound 2 −8.14 1,080 4.7 √ √ - √ - - √ -
5 Compound 3 −8.35 752.52 2.7 √ √ - √ √ - √ -
6 Compound 4 −8.66 448.43 2.2 √ √ - √ √ - √ -
7 Compound 5 −6.78 10,740 2.7 √ √ √ - √ √ √ √
8 Compound 6 −7.65 2,470 2.1 √ √ √ √ √ - √ -
9 Compound 7 −4.99 218,680 6.2 - - - - √ √ √ √
10 Compound 8 −8.58 517.42 2.9 √ √ - √ - - √ -
11 Compound 9 −8.30 831.04 2.8 √ √ √ √ √ - √ -
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result. Therefore, it is essential to proceed to further study, mainly 
isolation and identification of active compounds as ACE inhibitors 
of this plant.
CONCLUSION
In conclusion, we have conducted in silico molecular 
docking to study the potential of polyphenol compounds from P. 
pellucida as an ACE inhibitor. The crystal structure of ACE (PDB id: 
1UZF) bound to captopril was used as a protein target. Based on the 
docking result showed that the native ligand (captopril) was obtained 
RMSD value of 0.96Á (<2), which means the docking results were 
valid with a ∆G value of −6.36 and clusters of 92% for the total of 
100 times running. Based on the interaction of ACE binding site, 
Compound 5 shows the most similar interaction with the captopril 
ligand where the compound binds to the active side of ACE compared 
to other compounds. Therefore, these results are preliminary data for 
further research with predictions of biological activity and interaction 
quickly, accurately, and inexpensively from the target compound.
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inhibitory concentration; LGA: Lamarckian Genetic Algorithm; 
Lys: Lysine; MMFF94: Merck Molecular Force Field 94; P. 
pellucida: Peperomia pellucida (L) Kunth; PDB: Protein Data 
Bank; RMSD: Root Mean Square Deviation; Tyr: Tyrosine.
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